Implantable Drug-Eluting Devices Market, Global Outlook and Forecast 2022-2028
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
This report contains market size and forecasts of Implantable Drug-Eluting Devices in global, including the following market information:
Global Implantable Drug-Eluting Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Drug-Eluting Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Implantable Drug-Eluting Devices companies in 2021 (%)
The global Implantable Drug-Eluting Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Drug Infusion Pumps Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Drug-Eluting Devices include Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation and Titan Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Implantable Drug-Eluting Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Drug-Eluting Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Type, 2021 (%)
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Application, 2021 (%)
Global Implantable Drug-Eluting Devices Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Implantable Drug-Eluting Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Drug-Eluting Devices revenues share in global market, 2021 (%)
Key companies Implantable Drug-Eluting Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Implantable Drug-Eluting Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Implantable Drug-Eluting Devices in global, including the following market information:
Global Implantable Drug-Eluting Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Drug-Eluting Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Implantable Drug-Eluting Devices companies in 2021 (%)
The global Implantable Drug-Eluting Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Drug Infusion Pumps Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Drug-Eluting Devices include Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation and Titan Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Implantable Drug-Eluting Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Drug-Eluting Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Type, 2021 (%)
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Application, 2021 (%)
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others
Global Implantable Drug-Eluting Devices Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Implantable Drug-Eluting Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Drug-Eluting Devices revenues share in global market, 2021 (%)
Key companies Implantable Drug-Eluting Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Implantable Drug-Eluting Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Medtronic
- Merck
- Bayer AG
- Johnson & Johnson
- Abbott
- Surmodics
- Boston Scientific Corporation
- Titan Pharmaceuticals, Inc.
- BIOTRONIK
- Allergan
- Bausch & Lomb
- REVA Medical
- MicroPort Medical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Implantable Drug-Eluting Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Drug-Eluting Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES OVERALL MARKET SIZE
2.1 Global Implantable Drug-Eluting Devices Market Size: 2021 VS 2028
2.2 Global Implantable Drug-Eluting Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Implantable Drug-Eluting Devices Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Implantable Drug-Eluting Devices Players in Global Market
3.2 Top Global Implantable Drug-Eluting Devices Companies Ranked by Revenue
3.3 Global Implantable Drug-Eluting Devices Revenue by Companies
3.4 Global Implantable Drug-Eluting Devices Sales by Companies
3.5 Global Implantable Drug-Eluting Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Implantable Drug-Eluting Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Implantable Drug-Eluting Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Drug-Eluting Devices Players in Global Market
3.8.1 List of Global Tier 1 Implantable Drug-Eluting Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Drug-Eluting Devices Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Implantable Drug-Eluting Devices Market Size Markets, 2021 & 2028
4.1.2 Implantable Drug Infusion Pumps
4.1.3 Intraocular Drug-Eluting Devices
4.1.4 Contraceptive Drug-Eluting Devices
4.1.5 Drug-Eluting Stents
4.1.6 Others
4.2 By Type - Global Implantable Drug-Eluting Devices Revenue & Forecasts
4.2.1 By Type - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
4.2.2 By Type - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
4.2.3 By Type - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Implantable Drug-Eluting Devices Sales & Forecasts
4.3.1 By Type - Global Implantable Drug-Eluting Devices Sales, 2017-2022
4.3.2 By Type - Global Implantable Drug-Eluting Devices Sales, 2023-2028
4.3.3 By Type - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
4.4 By Type - Global Implantable Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Implantable Drug-Eluting Devices Market Size, 2021 & 2028
5.1.2 Diabetes
5.1.3 Contraception
5.1.4 HIV/AIDS Prevention
5.1.5 Chronic Pain Management
5.1.6 Cardiovascular
5.1.7 Ophthalmology
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Implantable Drug-Eluting Devices Revenue & Forecasts
5.2.1 By Application - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
5.2.2 By Application - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
5.2.3 By Application - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Implantable Drug-Eluting Devices Sales & Forecasts
5.3.1 By Application - Global Implantable Drug-Eluting Devices Sales, 2017-2022
5.3.2 By Application - Global Implantable Drug-Eluting Devices Sales, 2023-2028
5.3.3 By Application - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
5.4 By Application - Global Implantable Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Implantable Drug-Eluting Devices Market Size, 2021 & 2028
6.2 By Region - Global Implantable Drug-Eluting Devices Revenue & Forecasts
6.2.1 By Region - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
6.2.2 By Region - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
6.2.3 By Region - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Implantable Drug-Eluting Devices Sales & Forecasts
6.3.1 By Region - Global Implantable Drug-Eluting Devices Sales, 2017-2022
6.3.2 By Region - Global Implantable Drug-Eluting Devices Sales, 2023-2028
6.3.3 By Region - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Implantable Drug-Eluting Devices Revenue, 2017-2028
6.4.2 By Country - North America Implantable Drug-Eluting Devices Sales, 2017-2028
6.4.3 US Implantable Drug-Eluting Devices Market Size, 2017-2028
6.4.4 Canada Implantable Drug-Eluting Devices Market Size, 2017-2028
6.4.5 Mexico Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Implantable Drug-Eluting Devices Revenue, 2017-2028
6.5.2 By Country - Europe Implantable Drug-Eluting Devices Sales, 2017-2028
6.5.3 Germany Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.4 France Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.5 U.K. Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.6 Italy Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.7 Russia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.8 Nordic Countries Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.9 Benelux Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Implantable Drug-Eluting Devices Revenue, 2017-2028
6.6.2 By Region - Asia Implantable Drug-Eluting Devices Sales, 2017-2028
6.6.3 China Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.4 Japan Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.5 South Korea Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.6 Southeast Asia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.7 India Implantable Drug-Eluting Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Implantable Drug-Eluting Devices Revenue, 2017-2028
6.7.2 By Country - South America Implantable Drug-Eluting Devices Sales, 2017-2028
6.7.3 Brazil Implantable Drug-Eluting Devices Market Size, 2017-2028
6.7.4 Argentina Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, 2017-2028
6.8.3 Turkey Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.4 Israel Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.6 UAE Implantable Drug-Eluting Devices Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Implantable Drug-Eluting Devices Major Product Offerings
7.1.4 Pfizer Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Implantable Drug-Eluting Devices Major Product Offerings
7.2.4 Medtronic Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.2.5 Medtronic Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Implantable Drug-Eluting Devices Major Product Offerings
7.3.4 Merck Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Implantable Drug-Eluting Devices Major Product Offerings
7.4.4 Bayer AG Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.4.5 Bayer AG Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Major Product Offerings
7.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Implantable Drug-Eluting Devices Major Product Offerings
7.6.4 Abbott Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.6.5 Abbott Key News
7.7 Surmodics
7.7.1 Surmodics Corporate Summary
7.7.2 Surmodics Business Overview
7.7.3 Surmodics Implantable Drug-Eluting Devices Major Product Offerings
7.7.4 Surmodics Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.7.5 Surmodics Key News
7.8 Boston Scientific Corporation
7.8.1 Boston Scientific Corporation Corporate Summary
7.8.2 Boston Scientific Corporation Business Overview
7.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Major Product Offerings
7.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.8.5 Boston Scientific Corporation Key News
7.9 Titan Pharmaceuticals, Inc.
7.9.1 Titan Pharmaceuticals, Inc. Corporate Summary
7.9.2 Titan Pharmaceuticals, Inc. Business Overview
7.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Major Product Offerings
7.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.9.5 Titan Pharmaceuticals, Inc. Key News
7.10 BIOTRONIK
7.10.1 BIOTRONIK Corporate Summary
7.10.2 BIOTRONIK Business Overview
7.10.3 BIOTRONIK Implantable Drug-Eluting Devices Major Product Offerings
7.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.10.5 BIOTRONIK Key News
7.11 Allergan
7.11.1 Allergan Corporate Summary
7.11.2 Allergan Implantable Drug-Eluting Devices Business Overview
7.11.3 Allergan Implantable Drug-Eluting Devices Major Product Offerings
7.11.4 Allergan Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.11.5 Allergan Key News
7.12 Bausch & Lomb
7.12.1 Bausch & Lomb Corporate Summary
7.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Business Overview
7.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Major Product Offerings
7.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.12.5 Bausch & Lomb Key News
7.13 REVA Medical
7.13.1 REVA Medical Corporate Summary
7.13.2 REVA Medical Implantable Drug-Eluting Devices Business Overview
7.13.3 REVA Medical Implantable Drug-Eluting Devices Major Product Offerings
7.13.4 REVA Medical Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.13.5 REVA Medical Key News
7.14 MicroPort Medical
7.14.1 MicroPort Medical Corporate Summary
7.14.2 MicroPort Medical Business Overview
7.14.3 MicroPort Medical Implantable Drug-Eluting Devices Major Product Offerings
7.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.14.5 MicroPort Medical Key News
8 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Implantable Drug-Eluting Devices Production Capacity, 2017-2028
8.2 Implantable Drug-Eluting Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Drug-Eluting Devices Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IMPLANTABLE DRUG-ELUTING DEVICES SUPPLY CHAIN ANALYSIS
10.1 Implantable Drug-Eluting Devices Industry Value Chain
10.2 Implantable Drug-Eluting Devices Upstream Market
10.3 Implantable Drug-Eluting Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Drug-Eluting Devices Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Implantable Drug-Eluting Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Drug-Eluting Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES OVERALL MARKET SIZE
2.1 Global Implantable Drug-Eluting Devices Market Size: 2021 VS 2028
2.2 Global Implantable Drug-Eluting Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Implantable Drug-Eluting Devices Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Implantable Drug-Eluting Devices Players in Global Market
3.2 Top Global Implantable Drug-Eluting Devices Companies Ranked by Revenue
3.3 Global Implantable Drug-Eluting Devices Revenue by Companies
3.4 Global Implantable Drug-Eluting Devices Sales by Companies
3.5 Global Implantable Drug-Eluting Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Implantable Drug-Eluting Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Implantable Drug-Eluting Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Drug-Eluting Devices Players in Global Market
3.8.1 List of Global Tier 1 Implantable Drug-Eluting Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Drug-Eluting Devices Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Implantable Drug-Eluting Devices Market Size Markets, 2021 & 2028
4.1.2 Implantable Drug Infusion Pumps
4.1.3 Intraocular Drug-Eluting Devices
4.1.4 Contraceptive Drug-Eluting Devices
4.1.5 Drug-Eluting Stents
4.1.6 Others
4.2 By Type - Global Implantable Drug-Eluting Devices Revenue & Forecasts
4.2.1 By Type - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
4.2.2 By Type - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
4.2.3 By Type - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Implantable Drug-Eluting Devices Sales & Forecasts
4.3.1 By Type - Global Implantable Drug-Eluting Devices Sales, 2017-2022
4.3.2 By Type - Global Implantable Drug-Eluting Devices Sales, 2023-2028
4.3.3 By Type - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
4.4 By Type - Global Implantable Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Implantable Drug-Eluting Devices Market Size, 2021 & 2028
5.1.2 Diabetes
5.1.3 Contraception
5.1.4 HIV/AIDS Prevention
5.1.5 Chronic Pain Management
5.1.6 Cardiovascular
5.1.7 Ophthalmology
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Implantable Drug-Eluting Devices Revenue & Forecasts
5.2.1 By Application - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
5.2.2 By Application - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
5.2.3 By Application - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Implantable Drug-Eluting Devices Sales & Forecasts
5.3.1 By Application - Global Implantable Drug-Eluting Devices Sales, 2017-2022
5.3.2 By Application - Global Implantable Drug-Eluting Devices Sales, 2023-2028
5.3.3 By Application - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
5.4 By Application - Global Implantable Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Implantable Drug-Eluting Devices Market Size, 2021 & 2028
6.2 By Region - Global Implantable Drug-Eluting Devices Revenue & Forecasts
6.2.1 By Region - Global Implantable Drug-Eluting Devices Revenue, 2017-2022
6.2.2 By Region - Global Implantable Drug-Eluting Devices Revenue, 2023-2028
6.2.3 By Region - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Implantable Drug-Eluting Devices Sales & Forecasts
6.3.1 By Region - Global Implantable Drug-Eluting Devices Sales, 2017-2022
6.3.2 By Region - Global Implantable Drug-Eluting Devices Sales, 2023-2028
6.3.3 By Region - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Implantable Drug-Eluting Devices Revenue, 2017-2028
6.4.2 By Country - North America Implantable Drug-Eluting Devices Sales, 2017-2028
6.4.3 US Implantable Drug-Eluting Devices Market Size, 2017-2028
6.4.4 Canada Implantable Drug-Eluting Devices Market Size, 2017-2028
6.4.5 Mexico Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Implantable Drug-Eluting Devices Revenue, 2017-2028
6.5.2 By Country - Europe Implantable Drug-Eluting Devices Sales, 2017-2028
6.5.3 Germany Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.4 France Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.5 U.K. Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.6 Italy Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.7 Russia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.8 Nordic Countries Implantable Drug-Eluting Devices Market Size, 2017-2028
6.5.9 Benelux Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Implantable Drug-Eluting Devices Revenue, 2017-2028
6.6.2 By Region - Asia Implantable Drug-Eluting Devices Sales, 2017-2028
6.6.3 China Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.4 Japan Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.5 South Korea Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.6 Southeast Asia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.6.7 India Implantable Drug-Eluting Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Implantable Drug-Eluting Devices Revenue, 2017-2028
6.7.2 By Country - South America Implantable Drug-Eluting Devices Sales, 2017-2028
6.7.3 Brazil Implantable Drug-Eluting Devices Market Size, 2017-2028
6.7.4 Argentina Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, 2017-2028
6.8.3 Turkey Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.4 Israel Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Implantable Drug-Eluting Devices Market Size, 2017-2028
6.8.6 UAE Implantable Drug-Eluting Devices Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Implantable Drug-Eluting Devices Major Product Offerings
7.1.4 Pfizer Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Implantable Drug-Eluting Devices Major Product Offerings
7.2.4 Medtronic Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.2.5 Medtronic Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Implantable Drug-Eluting Devices Major Product Offerings
7.3.4 Merck Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Implantable Drug-Eluting Devices Major Product Offerings
7.4.4 Bayer AG Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.4.5 Bayer AG Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Major Product Offerings
7.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Implantable Drug-Eluting Devices Major Product Offerings
7.6.4 Abbott Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.6.5 Abbott Key News
7.7 Surmodics
7.7.1 Surmodics Corporate Summary
7.7.2 Surmodics Business Overview
7.7.3 Surmodics Implantable Drug-Eluting Devices Major Product Offerings
7.7.4 Surmodics Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.7.5 Surmodics Key News
7.8 Boston Scientific Corporation
7.8.1 Boston Scientific Corporation Corporate Summary
7.8.2 Boston Scientific Corporation Business Overview
7.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Major Product Offerings
7.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.8.5 Boston Scientific Corporation Key News
7.9 Titan Pharmaceuticals, Inc.
7.9.1 Titan Pharmaceuticals, Inc. Corporate Summary
7.9.2 Titan Pharmaceuticals, Inc. Business Overview
7.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Major Product Offerings
7.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.9.5 Titan Pharmaceuticals, Inc. Key News
7.10 BIOTRONIK
7.10.1 BIOTRONIK Corporate Summary
7.10.2 BIOTRONIK Business Overview
7.10.3 BIOTRONIK Implantable Drug-Eluting Devices Major Product Offerings
7.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.10.5 BIOTRONIK Key News
7.11 Allergan
7.11.1 Allergan Corporate Summary
7.11.2 Allergan Implantable Drug-Eluting Devices Business Overview
7.11.3 Allergan Implantable Drug-Eluting Devices Major Product Offerings
7.11.4 Allergan Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.11.5 Allergan Key News
7.12 Bausch & Lomb
7.12.1 Bausch & Lomb Corporate Summary
7.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Business Overview
7.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Major Product Offerings
7.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.12.5 Bausch & Lomb Key News
7.13 REVA Medical
7.13.1 REVA Medical Corporate Summary
7.13.2 REVA Medical Implantable Drug-Eluting Devices Business Overview
7.13.3 REVA Medical Implantable Drug-Eluting Devices Major Product Offerings
7.13.4 REVA Medical Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.13.5 REVA Medical Key News
7.14 MicroPort Medical
7.14.1 MicroPort Medical Corporate Summary
7.14.2 MicroPort Medical Business Overview
7.14.3 MicroPort Medical Implantable Drug-Eluting Devices Major Product Offerings
7.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.14.5 MicroPort Medical Key News
8 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Implantable Drug-Eluting Devices Production Capacity, 2017-2028
8.2 Implantable Drug-Eluting Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Drug-Eluting Devices Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IMPLANTABLE DRUG-ELUTING DEVICES SUPPLY CHAIN ANALYSIS
10.1 Implantable Drug-Eluting Devices Industry Value Chain
10.2 Implantable Drug-Eluting Devices Upstream Market
10.3 Implantable Drug-Eluting Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Drug-Eluting Devices Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Implantable Drug-Eluting Devices in Global Market
Table 2. Top Implantable Drug-Eluting Devices Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Implantable Drug-Eluting Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Implantable Drug-Eluting Devices Revenue Share by Companies, 2017-2022
Table 5. Global Implantable Drug-Eluting Devices Sales by Companies, (K Units), 2017-2022
Table 6. Global Implantable Drug-Eluting Devices Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Implantable Drug-Eluting Devices Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Implantable Drug-Eluting Devices Product Type
Table 9. List of Global Tier 1 Implantable Drug-Eluting Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Implantable Drug-Eluting Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 15. By Type - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 16. By Application – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 20. By Application - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 21. By Region – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 25. By Region - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 26. By Country - North America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 29. By Country - North America Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 30. By Country - Europe Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 33. By Country - Europe Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 34. By Region - Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 37. By Region - Asia Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 38. By Country - South America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 41. By Country - South America Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Implantable Drug-Eluting Devices Product Offerings
Table 48. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Medtronic Corporate Summary
Table 50. Medtronic Implantable Drug-Eluting Devices Product Offerings
Table 51. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Implantable Drug-Eluting Devices Product Offerings
Table 54. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bayer AG Corporate Summary
Table 56. Bayer AG Implantable Drug-Eluting Devices Product Offerings
Table 57. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Implantable Drug-Eluting Devices Product Offerings
Table 60. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Abbott Corporate Summary
Table 62. Abbott Implantable Drug-Eluting Devices Product Offerings
Table 63. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Surmodics Corporate Summary
Table 65. Surmodics Implantable Drug-Eluting Devices Product Offerings
Table 66. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Boston Scientific Corporation Corporate Summary
Table 68. Boston Scientific Corporation Implantable Drug-Eluting Devices Product Offerings
Table 69. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Titan Pharmaceuticals, Inc. Corporate Summary
Table 71. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Offerings
Table 72. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. BIOTRONIK Corporate Summary
Table 74. BIOTRONIK Implantable Drug-Eluting Devices Product Offerings
Table 75. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Allergan Corporate Summary
Table 77. Allergan Implantable Drug-Eluting Devices Product Offerings
Table 78. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Bausch & Lomb Corporate Summary
Table 80. Bausch & Lomb Implantable Drug-Eluting Devices Product Offerings
Table 81. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. REVA Medical Corporate Summary
Table 83. REVA Medical Implantable Drug-Eluting Devices Product Offerings
Table 84. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. MicroPort Medical Corporate Summary
Table 86. MicroPort Medical Implantable Drug-Eluting Devices Product Offerings
Table 87. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Implantable Drug-Eluting Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Implantable Drug-Eluting Devices Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Implantable Drug-Eluting Devices Production by Region, 2017-2022 (K Units)
Table 91. Global Implantable Drug-Eluting Devices Production by Region, 2023-2028 (K Units)
Table 92. Implantable Drug-Eluting Devices Market Opportunities & Trends in Global Market
Table 93. Implantable Drug-Eluting Devices Market Drivers in Global Market
Table 94. Implantable Drug-Eluting Devices Market Restraints in Global Market
Table 95. Implantable Drug-Eluting Devices Raw Materials
Table 96. Implantable Drug-Eluting Devices Raw Materials Suppliers in Global Market
Table 97. Typical Implantable Drug-Eluting Devices Downstream
Table 98. Implantable Drug-Eluting Devices Downstream Clients in Global Market
Table 99. Implantable Drug-Eluting Devices Distributors and Sales Agents in Global Market
Table 1. Key Players of Implantable Drug-Eluting Devices in Global Market
Table 2. Top Implantable Drug-Eluting Devices Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Implantable Drug-Eluting Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Implantable Drug-Eluting Devices Revenue Share by Companies, 2017-2022
Table 5. Global Implantable Drug-Eluting Devices Sales by Companies, (K Units), 2017-2022
Table 6. Global Implantable Drug-Eluting Devices Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Implantable Drug-Eluting Devices Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Implantable Drug-Eluting Devices Product Type
Table 9. List of Global Tier 1 Implantable Drug-Eluting Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Implantable Drug-Eluting Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 15. By Type - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 16. By Application – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 20. By Application - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 21. By Region – Global Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Implantable Drug-Eluting Devices Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Implantable Drug-Eluting Devices Sales (K Units), 2017-2022
Table 25. By Region - Global Implantable Drug-Eluting Devices Sales (K Units), 2023-2028
Table 26. By Country - North America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 29. By Country - North America Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 30. By Country - Europe Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 33. By Country - Europe Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 34. By Region - Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 37. By Region - Asia Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 38. By Country - South America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 41. By Country - South America Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Implantable Drug-Eluting Devices Product Offerings
Table 48. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Medtronic Corporate Summary
Table 50. Medtronic Implantable Drug-Eluting Devices Product Offerings
Table 51. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Implantable Drug-Eluting Devices Product Offerings
Table 54. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bayer AG Corporate Summary
Table 56. Bayer AG Implantable Drug-Eluting Devices Product Offerings
Table 57. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Implantable Drug-Eluting Devices Product Offerings
Table 60. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Abbott Corporate Summary
Table 62. Abbott Implantable Drug-Eluting Devices Product Offerings
Table 63. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Surmodics Corporate Summary
Table 65. Surmodics Implantable Drug-Eluting Devices Product Offerings
Table 66. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Boston Scientific Corporation Corporate Summary
Table 68. Boston Scientific Corporation Implantable Drug-Eluting Devices Product Offerings
Table 69. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Titan Pharmaceuticals, Inc. Corporate Summary
Table 71. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Offerings
Table 72. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. BIOTRONIK Corporate Summary
Table 74. BIOTRONIK Implantable Drug-Eluting Devices Product Offerings
Table 75. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Allergan Corporate Summary
Table 77. Allergan Implantable Drug-Eluting Devices Product Offerings
Table 78. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Bausch & Lomb Corporate Summary
Table 80. Bausch & Lomb Implantable Drug-Eluting Devices Product Offerings
Table 81. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. REVA Medical Corporate Summary
Table 83. REVA Medical Implantable Drug-Eluting Devices Product Offerings
Table 84. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. MicroPort Medical Corporate Summary
Table 86. MicroPort Medical Implantable Drug-Eluting Devices Product Offerings
Table 87. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Implantable Drug-Eluting Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Implantable Drug-Eluting Devices Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Implantable Drug-Eluting Devices Production by Region, 2017-2022 (K Units)
Table 91. Global Implantable Drug-Eluting Devices Production by Region, 2023-2028 (K Units)
Table 92. Implantable Drug-Eluting Devices Market Opportunities & Trends in Global Market
Table 93. Implantable Drug-Eluting Devices Market Drivers in Global Market
Table 94. Implantable Drug-Eluting Devices Market Restraints in Global Market
Table 95. Implantable Drug-Eluting Devices Raw Materials
Table 96. Implantable Drug-Eluting Devices Raw Materials Suppliers in Global Market
Table 97. Typical Implantable Drug-Eluting Devices Downstream
Table 98. Implantable Drug-Eluting Devices Downstream Clients in Global Market
Table 99. Implantable Drug-Eluting Devices Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Implantable Drug-Eluting Devices Segment by Type
Figure 2. Implantable Drug-Eluting Devices Segment by Application
Figure 3. Global Implantable Drug-Eluting Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Implantable Drug-Eluting Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Implantable Drug-Eluting Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. Implantable Drug-Eluting Devices Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Implantable Drug-Eluting Devices Revenue in 2021
Figure 9. By Type - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 10. By Type - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 11. By Type - Global Implantable Drug-Eluting Devices Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 13. By Application - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 14. By Application - Global Implantable Drug-Eluting Devices Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 16. By Region - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 17. By Country - North America Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 18. By Country - North America Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 19. US Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 24. Germany Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 25. France Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 33. China Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 37. India Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 39. By Country - South America Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 40. Brazil Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 44. Turkey Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 48. Global Implantable Drug-Eluting Devices Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Implantable Drug-Eluting Devices by Region, 2021 VS 2028
Figure 50. Implantable Drug-Eluting Devices Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Implantable Drug-Eluting Devices Segment by Type
Figure 2. Implantable Drug-Eluting Devices Segment by Application
Figure 3. Global Implantable Drug-Eluting Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Implantable Drug-Eluting Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Implantable Drug-Eluting Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. Implantable Drug-Eluting Devices Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Implantable Drug-Eluting Devices Revenue in 2021
Figure 9. By Type - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 10. By Type - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 11. By Type - Global Implantable Drug-Eluting Devices Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 13. By Application - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 14. By Application - Global Implantable Drug-Eluting Devices Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 16. By Region - Global Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 17. By Country - North America Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 18. By Country - North America Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 19. US Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 24. Germany Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 25. France Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 33. China Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 37. India Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 39. By Country - South America Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 40. Brazil Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share, 2017-2028
Figure 44. Turkey Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Implantable Drug-Eluting Devices Revenue, (US$, Mn), 2017-2028
Figure 48. Global Implantable Drug-Eluting Devices Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Implantable Drug-Eluting Devices by Region, 2021 VS 2028
Figure 50. Implantable Drug-Eluting Devices Industry Value Chain
Figure 51. Marketing Channels
